You are here
Global miRNA Sequencing & Assay Market Expected to Reach $343 Million by 2024 - Leading Players are Illumina, Thermo Fisher Scientific, QIAGEN, New England Biolabs, and Takara Bio
DUBLIN, March 14, 2019 /PRNewswire/ -- The "miRNA Sequencing and Assay Market by Product (Library Preparation, Consumables), Technology (Sequencing By Synthesis, Nanopore, Ion Semiconductor Sequencing), End User (Research Institute, Academia, CRO), Region - Global Forecast To 2024" report has been added to ResearchAndMarkets.com's offering.
The miRNA sequencing and assays market is projected to reach USD 343 million by 2024 from USD 182 million in 2018, at a CAGR of 11.2%.
The miRNA sequencing and assays market is driven by various factors such as the advantages of miRNA sequencing over other technologies, increasing research funding for genomics, and the decreasing cost of sequencing. However, the dearth of skilled professionals is expected to limit market growth to a certain extent.
Based on product, the miRNA sequencing & assays market is segmented into library preparation kits and sequencing consumables. Sequencing consumables dominated the market with a larger share in 2018. The large share of this segment can primarily be attributed to the repeat purchases of kits due to their high requirement and the high costs compared to library preparation kits.
By technology, the miRNA sequencing & assays market is segmented into sequencing by synthesis, ion semiconductor sequencing, SOLiD, and Nanopore sequencing. The sequencing by synthesis segment dominated the market with the largest share in 2018 due to the technological advancements in sequencing by synthesis platforms and the reduced cost of sequencing.
The APAC miRNA sequencing and assays market, particularly in China, Japan, South Korea, Singapore, and India is expected to witness high growth in the next five years. The rising R&D funding for life sciences research, rapid growth of its life sciences industry, increasing adoption of NGS for miRNA analysis are the major factors driving the growth of this market.
The key players operating in the miRNA sequencing and assays market are Illumina (US), Thermo Fisher Scientific (US), QIAGEN (Germany), New England Biolabs (UK), and Takara Bio (Japan). A majority of the leading players in the market focus on both organic and inorganic growth strategies such as collaborations, partnerships, acquisitions, and agreements to maintain and enhance their market shares in the miRNA sequencing & assays market.
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Research
18.104.22.168 Key Data From Secondary Sources
2.1.2 Primary Research
22.214.171.124 Key Data From Primary Sources
126.96.36.199 Break Down of Primaries
188.8.131.52 Key Industry Insights
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 miRNA Sequencing & Assays Market Overview
4.2 miRNA Sequencing & Assays Market, By Technology (2016-2024)
4.3 North America: miRNA Sequencing & Assays Market, By Product (2018)
5 Market Overview
5.2 Market Dynamics
5.2.1 Market Drivers
184.108.40.206 Advantages of miRNA Sequencing Over Other Technologies
220.127.116.11 Increasing Research Funding for Genomics
18.104.22.168 Decreasing Cost of Sequencing
5.2.2 Market Opportunities
22.214.171.124 Increasing Focus on miRNA Biomarker Discovery
5.2.3 Market Challenges
126.96.36.199 Dearth of Skilled Professionals
6 miRNA Sequencing and Assays Market, By Product
6.2 Sequencing Consumables
6.2.1 Increasing Demand for miRNA Sequencing is Boosting the Adoption of Sequencing Consumables
6.3 Library Preparation Kits
6.3.1 Library Preparation Kits Segment to Grow at the Highest Cagr During the Forecast Period
7 miRNA Sequencing and Assays Market, By Technology
7.2 Sequencing By Synthesis
7.2.1 Sequencing By Synthesis Segment Accounted for the Largest Market Share in 2018
7.3 Ion Semiconductor Sequencing
7.3.1 Platforms Developed Using This Technology are Low-Cost Instruments and Possess High-Throughput Capabilities
7.4 Sequencing By Oligonucleotide Ligation and Detection
7.4.1 Solid Sequencing Offers Accurate Sequencing of Short Reads
7.5 Nanopore Sequencing
7.5.1 Nanopore Sequencing Segment to Witness the Highest Growth During the Forecast Period
8 miRNA Sequencing and Assays Market, By End User
8.2 Research and Academic Institutes
8.2.1 Research and Academic Institutes Segment to Dominate This Segment
8.3 Contract Research Organizations
8.3.1 Contract Research Organizations Such as Genomics Services Companies to Grow at Highest Cagr"
9 miRNA Sequencing and Assays Market, By Region
9.2 North America
188.8.131.52 US Dominates the North American miRNA Sequencing and Assays Market, Due to the Favorable Funding Scenario for Research and StroPlayers
184.108.40.206 Increase in Genomics Research to Drive the Adoption of miRNA Sequencing in Canada
220.127.116.11 Growth of the Genomics Market to Drive the Growth of the Market Growth
18.104.22.168 Government Initiatives in Genomics to Drive the Market for miRNA Sequencing
9.4 Asia Pacific
9.5 Rest of the World
10 Competitive Landscape
10.2 Vendor Benchmarking
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Market Ranking Analysis, 2017
10.5 Competitive Situation and Trends
10.5.1 Collaborations, Partnerships, and Agreements
10.5.2 Product Launches
11 Company Profiles
11.1 Illumina, Inc.
11.2 Thermo Fisher Scientific
11.4 Perkinelmer, Inc.
11.5 Takara Bio, Inc.
11.6 New England Biolabs, Inc.
11.7 Norgen Biotek Corporation
11.8 Trilink Biotechnologies
11.10 Oxford Nanopore Technologies
For more information about this report visit https://www.researchandmarkets.com/research/s68pjs/global_mirna?w=5
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-mirna-sequencing--assay-market-expected-to-reach-343-million-by-2024---leading-players-are-illumina-thermo-fisher-scientific-qiagen-new-england-biolabs-and-takara-bio-300812434.html
SOURCE Research and Markets